February 13, 2026 10:38 AM
Live Updates: Sun Pharmaceutical Industries Ltd Stock Loses Ground Today, Falls -0.92%
Sun Pharmaceutical Industries Ltd experienced a -0.92% dip in its share price and is currently trading at 1699.10. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 13, 2026 10:08 AM
Sun Pharmaceutical Industries Ltd Stock Drops in Today's Trading Session
Sun Pharmaceutical Industries Ltd's share price has dropped by -0.92%, a development that warrants careful analysis. Presently trading at 1699.10, investors are assessing whether this presents an opportunity or a risk.
February 13, 2026 9:38 AM
Real-Time Market Data: Sun Pharmaceutical Industries Ltd Share Price Drops
The stock of Sun Pharmaceutical Industries Ltd is facing a -0.79% decline and is currently trading at 1701.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.
February 13, 2026 9:08 AM
Sun Pharmaceutical Industries Ltd Stock Drops in Today's Trading Session
Sun Pharmaceutical Industries Ltd's share price has dropped by -0.79%, a development that warrants careful analysis. Presently trading at 1701.30, investors are assessing whether this presents an opportunity or a risk.
February 13, 2026 8:38 AM
Sun Pharmaceutical Industries Ltd Stock Slides Today
Sun Pharmaceutical Industries Ltd observed a -0.29% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1710.00. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 13, 2026 8:08 AM
Today's Trading Session: Sun Pharmaceutical Industries Ltd Share Price Declines by -0.29%
Sun Pharmaceutical Industries Ltd experienced a -0.29% downturn in its share price, and it's currently trading at 1710.00. This situation is generating interest among value investors who are evaluating the stock's potential.
February 13, 2026 7:38 AM
Live Market Data: Sun Pharmaceutical Industries Ltd Share Price Down -0.41% Today
Sun Pharmaceutical Industries Ltd shares saw a -0.41% decrease, reaching a current market price of 1707.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 13, 2026 7:08 AM
Today's Trading Session: Sun Pharmaceutical Industries Ltd Stock Falls
With a -0.41% decrease, Sun Pharmaceutical Industries Ltd's share price is now at 1707.90. The stock is currently trading at a PE of 37.5600, while the industry PE is 32.0438, prompting investors to assess its value proposition.
February 13, 2026 6:38 AM
Today's Trading Session: Sun Pharmaceutical Industries Ltd Stock Falls
With a -0.17% decrease, Sun Pharmaceutical Industries Ltd's share price is now at 1711.90. The stock is currently trading at a PE of 37.5600, while the industry PE is 32.0438, prompting investors to assess its value proposition.
February 13, 2026 6:08 AM
Live Market Data: Sun Pharmaceutical Industries Ltd Share Price Down -0.17% Today
Sun Pharmaceutical Industries Ltd shares saw a -0.17% decrease, reaching a current market price of 1711.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 13, 2026 5:38 AM
Sun Pharmaceutical Industries Ltd Stock Slides Today
Sun Pharmaceutical Industries Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1711.10. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 13, 2026 5:08 AM
Live Market Data: Sun Pharmaceutical Industries Ltd Share Price Drops -0.22% Today
Sun Pharmaceutical Industries Ltd's share price has fallen by -0.22%, presenting both challenges and opportunities for investors. As of now, it's trading at 1711.10, and market participants are assessing the implications. The stock has a PE ratio of 37.5600, an ROE of 14.8407 and a debt to equity ratio of 0.0670.